DIETHYLPROPION HYDROCHLORIDE (Diethylpropion Hydrochloride ER) Nursing Considerations

What is the generic name?

DIETHYLPROPION HYDROCHLORIDE

What is the Trade Name for DIETHYLPROPION HYDROCHLORIDE?

Diethylpropion Hydrochloride ER

What are the Indications for DIETHYLPROPION HYDROCHLORIDE?

• INDICATIONS AND USAGE Diethylpropion hydrochloride extended release tablets, 75 mg are indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of 30 kg/m 2 or higher and who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. Below is a chart of BMI based on various heights and weights. BMI is calculated by taking the patient‚Äôs weight, in kilograms (kg), divided by the patient‚Äôs height, in meters (m), squared. Metric conversions are as follows: pounds divided by 2.2 = kg; inches x 0.0254 = meters. Body Mass Index (BMI), kg/m 2 Weight (pounds) Height (feet, inches) 5‚Äô0‚Äù 5‚Äô3‚Äù 5‚Äô6‚Äù 5‚Äô9‚Äù 6‚Äô0‚Äù 6‚Äô3‚Äù 140 27 25 23 21 19 18 150 29 27 24 22 20 19 160 31 28 26 24 22 20 170 33 30 28 25 23 21 180 35 32 29 27 25 23 190 37 34 31 28 26 24 200 39 36 32 30 27 25 210 41 37 34 31 29 26 220 43 39 36 33 30 28 230 45 41 37 34 31 29 240 47 43 39 36 33 30 250 49 44 40 37 34 31 The usefulness of agents of this class (See CLINICAL PHARMACOLOGY ) should be measured against possible risk factors inherent in their use such as those described below. Diethylpropion hydrochloride extended release tablets, 75 mg are indicated for use as monotherapy only.

References: https://open.fda.gov/